Skip to content
EUROCAM LOGO with slogan
Search
Donate
  • Home
  • Who we are
    • What is CAM
      • Benefits of CAM
      • Relevance for the EU
      • CAM modalities
      • CAM health professionals
      • CAM training and education in Europe
      • CAM regulation
      • CAM practice
    • What is IM
    • Affiliated organisations
    • Vision
    • Aims and objectives
    • Governance
    • Dedicated support team
  • What we do
    • MEP Interest Group on Integrative Medicine and Health
      • Guiding Principles MEP Interest Group
      • Event Integrative Medicine and Health, COVID-19 and long COVID
      • Online event Integrative Medicine and Health in Pain Management
      • Online event Integrative Oncology
      • Official launch of the MEP Interest Group on Integrative Medicine & Health
    • EU4Health CSA demands to do more for health
      • Campaign for a stronger European health policy
      • EU health organisations react on cuts in EU health programme
    • COVID-19 and the immune system
    • Antimicrobial resistance
      • Resolving AMR by reducing the reliance on antibiotic treatment
      • Statement on AntiMicrobial Resistance 2021
      • CAM-AMR Conference
      • Manifesto on antimicrobial resistance
    • CAM in the context of cancer
    • European Parliament 2019 -2024
      • EU4Health Programme
      • ENVI Committee webinar Complementary and Integrative Medicine
    • European Parliament 2014-2019
      • EU directives are not working for products used in CAM
      • CAM interest group European Parliament 2014-2019
        • CAM and musculoskeletal disorders
        • Ensuring the availability of CAM medicinal products
        • CAM – Reducing the need for antibiotics
        • CAM an investment in health
        • Cancer and the contribution of CAM
        • The need for research
        • Healthy ageing
      • CAM Conferences
        • ENVI committee workshop on CAM
        • CAM innovation and added value for the EU
      • EP docs on CAM
    • European Commission
      • Pharmaceutical Strategy
      • European Commission and CAM
      • EC docs on CAM
    • World Health Organization
      • WHO, European Programme of Work
  • Library
    • Publications
    • Position papers
      • Prevention and management COVID19, position paper
      • The role of CAM and Integrative Oncology
      • Healthy ageing, position paper
      • Resolving AMR by reducing the reliance on antibiotic treatment 2
      • Availability of CAM medicinal products, position paper
      • Research priorities for its use in citizens’ health, position paper
    • Cambrella reports
    • Knowledge exchange
    • Archive
  • Research
    • Complementary and Alternative Medicine
    • Acupuncture
    • Anthroposophic medicine
    • Ayurveda
    • Chiropractic
    • Herbal medicine
    • Homeopathy
    • Naturopathic medicine
    • Osteopathy
    • Reiki Therapy
    • Shiatsu
    • Traditional Chinese Medicine
    • Yoga
  • Links
  • Health news
    • Health news
    • Members’ news
    • EUROCAM newsletters
  • Contact
    • Press release
      • Press release event European Parliament about Integrative Oncology
    • Media kit
    • Factsheet
Donate
  • Home
  • Who we are
    • What is CAM
      • Benefits of CAM
      • Relevance for the EU
      • CAM modalities
      • CAM health professionals
      • CAM training and education in Europe
      • CAM regulation
      • CAM practice
    • What is IM
    • Affiliated organisations
    • Vision
    • Aims and objectives
    • Governance
    • Dedicated support team
  • What we do
    • MEP Interest Group on Integrative Medicine and Health
      • Guiding Principles MEP Interest Group
      • Event Integrative Medicine and Health, COVID-19 and long COVID
      • Online event Integrative Medicine and Health in Pain Management
      • Online event Integrative Oncology
      • Official launch of the MEP Interest Group on Integrative Medicine & Health
    • EU4Health CSA demands to do more for health
      • Campaign for a stronger European health policy
      • EU health organisations react on cuts in EU health programme
    • COVID-19 and the immune system
    • Antimicrobial resistance
      • Resolving AMR by reducing the reliance on antibiotic treatment
      • Statement on AntiMicrobial Resistance 2021
      • CAM-AMR Conference
      • Manifesto on antimicrobial resistance
    • CAM in the context of cancer
    • European Parliament 2019 -2024
      • EU4Health Programme
      • ENVI Committee webinar Complementary and Integrative Medicine
    • European Parliament 2014-2019
      • EU directives are not working for products used in CAM
      • CAM interest group European Parliament 2014-2019
        • CAM and musculoskeletal disorders
        • Ensuring the availability of CAM medicinal products
        • CAM – Reducing the need for antibiotics
        • CAM an investment in health
        • Cancer and the contribution of CAM
        • The need for research
        • Healthy ageing
      • CAM Conferences
        • ENVI committee workshop on CAM
        • CAM innovation and added value for the EU
      • EP docs on CAM
    • European Commission
      • Pharmaceutical Strategy
      • European Commission and CAM
      • EC docs on CAM
    • World Health Organization
      • WHO, European Programme of Work
  • Library
    • Publications
    • Position papers
      • Prevention and management COVID19, position paper
      • The role of CAM and Integrative Oncology
      • Healthy ageing, position paper
      • Resolving AMR by reducing the reliance on antibiotic treatment 2
      • Availability of CAM medicinal products, position paper
      • Research priorities for its use in citizens’ health, position paper
    • Cambrella reports
    • Knowledge exchange
    • Archive
  • Research
    • Complementary and Alternative Medicine
    • Acupuncture
    • Anthroposophic medicine
    • Ayurveda
    • Chiropractic
    • Herbal medicine
    • Homeopathy
    • Naturopathic medicine
    • Osteopathy
    • Reiki Therapy
    • Shiatsu
    • Traditional Chinese Medicine
    • Yoga
  • Links
  • Health news
    • Health news
    • Members’ news
    • EUROCAM newsletters
  • Contact
    • Press release
      • Press release event European Parliament about Integrative Oncology
    • Media kit
    • Factsheet
EP docs on CAM

Parliament docs on CAM

The EP documents on CAM area provides relevant resolutions.

  • Resolution on the status of non-conventional medicine A4-0075/97

Secretariat

Rue du Trône 194
1050 Brussels
Belgium

+31 631 948 408

secretariat(at)cam-europe.eu

member login

Secretary-General

Dr Ton Nicolai

+31 650 613 430

secretary-general(at)cam-europe.eu 

Communication & PR

Miranda Ruchtie and Sonja Maric

communication(at)cam-europe.eu

Terms & conditions

Privacy Statement

© 2018 EUROCAM

Manage Cookie Consent
We use cookies to optimize our website and our service.
Functional Always active
The technical storage or access is strictly necessary for the legitimate purpose of enabling the use of a specific service explicitly requested by the subscriber or user, or for the sole purpose of carrying out the transmission of a communication over an electronic communications network.
Preferences
The technical storage or access is necessary for the legitimate purpose of storing preferences that are not requested by the subscriber or user.
Statistics
The technical storage or access that is used exclusively for statistical purposes. The technical storage or access that is used exclusively for anonymous statistical purposes. Without a subpoena, voluntary compliance on the part of your Internet Service Provider, or additional records from a third party, information stored or retrieved for this purpose alone cannot usually be used to identify you.
Marketing
The technical storage or access is required to create user profiles to send advertising, or to track the user on a website or across several websites for similar marketing purposes.
Manage options Manage services Manage vendors Read more about these purposes
Preferences
{title} {title} {title}